Karli Norville

Karli Norville has a diverse background in research. Karli began their career in 2013 as an Undergraduate Student Researcher at the Caselle Laboratory. Karli then moved to the University of California, Santa Barbara in 2015 to take a Research Immersion in Molecular Biosciences class, where they conducted research into the effects of the antidepressant Isocarboxazid on the development of C. intestinalis and the effects of knock-down of the gene C18A3.1 (damt-1) in C. Karli then moved to the DeTomaso Laboratory as an Undergraduate Student Researcher. In 2016, they began their PhD Candidate role at the University of Rochester. Most recently, in 2022, they began their role as Scientist I - Translational Research at OncoC4, Inc.

Karli Norville's education history includes a Doctor of Philosophy in Microbiology and Immunology from the University of Rochester School of Medicine and Dentistry, a Master's degree in Microbiology and Immunology from the same school, and a Bachelor's degree in Microbiology from the University of California, Santa Barbara.